Comparative effectiveness and safety of prasugrel versus ticagrelor following percutaneous coronary intervention: An observational study.

When compared with ticagrelor, prasugrel use following PCI for ACS was associated with a lower risk of death, MI, or stroke, as well as a reduced risk of major bleeding.